Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Desmond McGovern"'
Autor:
Ronald L. Korn, Daniel D. Von Hoff, Mitesh J. Borad, Markus F. Renschler, Desmond McGovern, R. Curtis Bay, Ramesh K. Ramanathan
Publikováno v:
Cancer Imaging, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Positron emission tomography (PET) is poised to become a useful imaging modality in staging and evaluating therapeutic responses in patients with metastatic pancreatic cancer (mPC). This analysis from a phase 1/2 study examined th
Externí odkaz:
https://doaj.org/article/716747d98fa044a3b00ee009aff4ab2a
Autor:
Michele Reni, David Goldstein, Chrystal U. Louis, Josep Tabernero, Marc F. Botteman, Abdalla Aly, Chee Khoon Lee, Daniel D. Von Hoff, Sandra Margunato-Debay, Desmond McGovern, Brian Lu, E. Gabriela Chiorean, Ramesh K. Ramanathan
Publikováno v:
Pancreas
Scientia
Scientia
Supplemental digital content is available in the text.
Objectives This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. Methods Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenoca
Objectives This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. Methods Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenoca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452c5bb5e6c9eb47f85549a3cb03f05a
https://doi.org/10.1097/mpa.0000000000001563
https://doi.org/10.1097/mpa.0000000000001563
Autor:
Wolfgang Janni, Denise A. Yardley, Vassilis Georgoulias, Nadia Harbeck, Xin Wei, Minetta C. Liu, Robert Beck, Desmond McGovern
Publikováno v:
Cancer Management and Research. 11:10427-10433
Purpose Circulating tumor cells (CTCs) are prognostic biomarkers in metastatic breast cancer, but their role in predicting treatment outcomes in metastatic triple-negative breast cancer (mTNBC) is less clear. The tnAcity trial demonstrated a signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::125fcd5512ea19e5607121687af28ea1
https://doi.org/10.2147/cmar.s208712
https://doi.org/10.2147/cmar.s208712
Autor:
Minetta C, Liu, Wolfgang, Janni, Vassilis, Georgoulias, Denise A, Yardley, Nadia, Harbeck, Xin, Wei, Desmond, McGovern, Robert, Beck
Publikováno v:
Cancer Management and Research
Purpose Circulating tumor cells (CTCs) are prognostic biomarkers in metastatic breast cancer, but their role in predicting treatment outcomes in metastatic triple-negative breast cancer (mTNBC) is less clear. The tnAcity trial demonstrated a signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25faf1e66812edb15546dc9929e250b3
https://pubmed.ncbi.nlm.nih.gov/31849532
https://pubmed.ncbi.nlm.nih.gov/31849532
Autor:
Volker Kunzmann, David Goldstein, Pascal Hammel, Ramesh K. Ramanathan, Desmond McGovern, Helen Liu, Werner Scheithauer, Alfredo Romano, Malcolm J. Moore, Daniel D. Von Hoff, Teresa Macarulla
Publikováno v:
Journal of Gastrointestinal Oncology. 7:469-478
Dose modifications following adverse events (AEs) are an important part of the management of patients with pancreatic cancer treated with chemotherapy. While dose modifications are utilized to ensure patient safety, the subsequent influence of dose a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a66f929cd60ab133caab3f5c176117e8
https://doi.org/10.21037/jgo.2016.01.03
https://doi.org/10.21037/jgo.2016.01.03
Autor:
David Goldstein, Elena G. Chiorean, Ramesh K. Ramanathan, Michele Reni, Daniel D. Von Hoff, Marc F. Botteman, Abdalla Aly, Chee Lee, Desmond McGovern, Brian Lu, Josep Tabernero, Sandra Margunato-Debay, Julia Wilkerson, Chrystal U. Louis, Markus F. Renschler
Publikováno v:
Annals of Oncology. 28:iii142-iii144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4a36e994fb35234f2be6786248549a5
https://doi.org/10.1093/annonc/mdx262.016
https://doi.org/10.1093/annonc/mdx262.016
Autor:
Andrew V. Biankin, Hanno Riess, Margaret A. Tempero, Michele Milella, Jordan Berlin, Mingyu Li, Philip A. Philip, Salvatore Siena, I.C. Ales-Diaz, J. Tabernero, Smitha S. Krishnamurthi, Y. Le Bruchec, Michele Reni, David Goldstein, Desmond McGovern, Stefano Ferrara, Eileen M. O'Reilly, Pia Österlund, E. Van Cutsem
Publikováno v:
Annals of Oncology. 30:v259-v260
Background The primary APACT analysis showed no significant difference in disease-free survival (DFS) by blinded, independent radiologic review with nab-P/G vs G in patients (pts) with surgically resected pancreatic cancer (PC). However, investigator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bf3c2fee67957265c6fcc59650ce165
https://doi.org/10.1093/annonc/mdz247.010
https://doi.org/10.1093/annonc/mdz247.010
Autor:
Josefine Römmler-Zehrer, Arndt Vogel, Michael Stahl, Alfredo Romano, Jack Shiansong Li, Desmond McGovern
Publikováno v:
BMC Cancer
Background The phase 3 MPACT trial in patients with metastatic pancreatic cancer demonstrated superior efficacy of nab-paclitaxel (nab-P) + gemcitabine (Gem) vs Gem monotherapy for all endpoints examined including overall survival, the primary endpoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96bfc5bd92ab829b3d55f7b2778eb2d2
http://europepmc.org/articles/PMC5073820
http://europepmc.org/articles/PMC5073820
Autor:
Xin Wei, Desmond McGovern, Minetta C. Liu, Robert Beck, Vassilis Georgoulias, Denise A. Yardley, Wolfgang Janni, Nadia Harbeck
Publikováno v:
Cancer Research. 78:4209-4209
Introduction Circulating tumor cells (CTCs) have been shown to be prognostic in patients (pts) with metastatic breast cancer (MBC) (Pukazhendhi, Gluck, J Carcinog. 2014). The tnAcity trial evaluated the efficacy/safety of 3 chemotherapy combination r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4920f93a44221f9902a255eedaf0116
https://doi.org/10.1158/1538-7445.am2018-4209
https://doi.org/10.1158/1538-7445.am2018-4209
Autor:
Ramesh K. Ramanathan, E. Gabriela Chiorean, Marc F. Botteman, Abdalla Aly, Josep Tabernero, Chee Khoon Lee, Michele Reni, Sandra Margunato-Debay, David Goldstein, Desmond McGovern, Brian Lu, Chrystal U. Louis, Julia Wilkersen, Markus F. Renschler, Daniel D. Von Hoff
Publikováno v:
Journal of Clinical Oncology. 35:4109-4109
4109 Background: Prognostic nomograms have been developed in various cancers, including ovarian, breast, and gastrointestinal; however, there is limited information on nomograms in MPC. The large, phase 3 MPACT study of nab-P + Gem vs Gem alone for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d34ce9d556a321bec09560f4baa7b57
https://doi.org/10.1200/jco.2017.35.15_suppl.4109
https://doi.org/10.1200/jco.2017.35.15_suppl.4109